Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for hemodynamic response during skull pin insertion
NCT03738059Phase 1Unknown
- Sponsor
- Assiut University
- Start
- Nov 2018
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of dexmedetomidine (4 arms), sponsored by Assiut University. Primary endpoints: Arterial blood pressure change and Heart rate change. Status: unknown.
02
Drugs
dexmedetomidine
Beyond the preview
Go deeper on NCT03738059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03738059.